Dapagliflozin fails to show a significant protective effect in COVID-19 Presented ByProf. Mikhail Kosiborod, Saint Luke’s Mid America Heart Institute, USA TrialDARE-19 ConferenceACC 2021 TypePeer-reviewed article 9 July 2021 23:46